Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  KHRNF | KHRWF | V.KHRN.WT.H

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

Recent & Breaking News (TSXV:KHRN.H)

Khiron Life Sciences Reports Third Quarter 2022 Financial Results

Canada NewsWire November 30, 2022

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022

PR Newswire November 18, 2022

Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom

PR Newswire November 16, 2022

Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference

PR Newswire September 13, 2022

Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California

PR Newswire September 1, 2022

Khiron Life Sciences Reports Second Quarter 2022 Financial Results

PR Newswire August 29, 2022

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022

PR Newswire August 22, 2022

Khiron Life Sciences Corp. to Present at Investor Summit Group's Q3 Virtual Conference

Newsfile August 10, 2022

Medical Cannabis Leader Khiron Opens Brazil's First Zerenia(TM) Clinic

PR Newswire August 9, 2022

Khiron Completes Acquisition of Pharmadrug Production GmbH, Establishing German Pharmaceutical Distribution Capabilities

PR Newswire August 2, 2022

Khiron Appoints Helen Bellwood (ACA) as Interim CFO

PR Newswire July 18, 2022

Medical Cannabis Leader Khiron Continues Global Expansion into Spain

PR Newswire July 6, 2022

Medical Cannabis Innovator Khiron Continues Global Expansion as Industry Leader Throughout Europe and Latin America

PR Newswire June 28, 2022

Khiron Announces Results of 2022 Annual General and Special Meeting

PR Newswire June 23, 2022

KHIRON LIFE SCIENCES ANNOUNCES CLOSING OF $4.6 MILLION OVERNIGHT BROKERED OFFERING INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTION

Canada NewsWire June 10, 2022

IIROC Trading Resumption - KHRN

Canada NewsWire June 2, 2022

KHIRON LIFE SCIENCES ANNOUNCES PRICING AND SIZE OF OVERNIGHT BROKERED OFFERING

Canada NewsWire June 2, 2022

IIROC Trading Halt - KHRN

Canada NewsWire June 2, 2022

KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT BROKERED OFFERING

Canada NewsWire June 1, 2022

Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint

PR Newswire May 31, 2022